Navigation Links

Terms and Conditions Of Use

These Terms and Conditions govern your use of the Bio-Medicine website ("the Site") and your relationship with us. Please read these terms and conditions and our privacy policy carefully before using the Site as they affect your rights and liabilities under the law. If you do not agree to these Terms and Conditions, please do not register for or use the Site. In these Terms and Conditions and in our privacy policy "we ", "us" and "our" means Bio-Medicine and its sites and "you" means the individual who is using the Site.

1. Use Of The Site.

The Site is provided to you free of charge for your personal use subject to these Terms and Conditions. By using the Site you agree to be bound by these Terms and Conditions.

All orders and purchases made on the Site will also be governed by these Terms and Conditions.

2. Amendments

We may update these Terms and Conditions from time to time and any changes will be notified to you via a suitable announcement on the Site. The changes will apply to the use of the Site after we have given notice. If you do not wish to accept the new Terms and Conditions you should not continue to use the Site. If you continue to use the Site after the date the change comes into effect, your use of the Site indicates your agreement to be bound by the new Terms and Conditions.

3. Availability of the Site

Although we aim to offer you the best service possible, we make no promise that the services at the Site will meet your requirements. We cannot guarantee that the service will be fault free.

Your access to the Site may be occasionally restricted to allow for repairs, maintenance or the introduction of new facilities or services. We will attempt to minimize the periods during which access to the Site is restricted for these reasons.

4. Our Intellectual Property Rights

We, or people we have contracted with, own or are licensed to use all the copyright, database rights or similar rights and information within the Site. You may use the information and reproduce it in hard copy for your personal use and reference only. Except where you are using a feature of the Site, such as "e-mail a friend", the information on the Site may not otherwise be reproduced, distributed or transmitted to any other person or incorporated in any way into another document or other material without our prior written approval. Any hard copies you make must retain all copyright and proprietary notices. You must not alter or try to alter any words, data, image or other item on the Site other than those items that are intended to be completed or changed by you.

5. Limitations

You may not use the Site for any of the following purposes:

  • Disseminating any unlawful, harassing, libelous, abusive, threatening, harmful, vulgar, obscene, otherwise objectionable material;
  • Transmitting material that encourages conduct that constitutes a criminal offence, results in civil liability or otherwise breaches any relevant laws, regulations or codes of practice;
  • Gaining unauthorized access to other computer systems;
  • Interfering with any other person's use or enjoyment of the Site;
  • Breaching any laws concerning the use of public telecommunications networks;
  • Interfering or disrupting networks or web sites connected to the Site; and
  • Making, transmitting or storing electronic copies of the materials protected by copyright without the permission of the owner.

You will indemnify us against all losses, liabilities, costs and expenses reasonably suffered or incurred by us, all damages awarded against us under any judgment by a court of competent jurisdiction and all settlement sums paid by us as a result of any settlement agreed by us arising out of or in connection with:

  • Any claim by any third party that the use of the Site by you is defamatory, offensive or abusive, or of an obscene or pornographic nature, or is illegal or constitutes a breach of any applicable law, regulation or code of practice;
  • Any claim by any third party that the use of the Site by you infringes that third party's copyright or other intellectual property rights of whatever nature; and
  • Any fines or penalties imposed by any regulatory, advertising or trading body or authority in connection with the use of the Site by you.

6. Bio-Medicine Liability

The Site is provided by us without any warranties or guarantees. You must bear the risks associated with the use of the Internet.

The Site provides content from other Internet sites or resources and while we try to ensure that the material included on the Site is correct, reputable and of high quality, it cannot accept responsibility if this is not the case.

We will not be responsible for any errors or omissions or for results obtained from the use of such information or for any technical problems you may experience with the Site. If we are informed of any inaccuracies in the material on the Site we will attempt to correct the inaccuracies as soon as we reasonably can.

In particular, we disclaim all liabilities in connection with the following:

  • Incompatibility of the Site with any of your equipment, software or telecommunications links;
  • Technical problems including errors or interruptions of the Site;
  • Unsuitability, unreliability or inaccuracy of the Site; and
  • Inadequacy of the Site to meet your requirements.

You agree that we will not be liable to you/or any third party for any consequential or incidental damages (including but not limited to loss of revenue, loss of profits, loss of privacy and loss of data) or any other indirect, special or punitive damages whatsoever that arise out of or are related to the Site.

Nothing in these Terms and Conditions shall exclude our liability for personal injury or death caused by its negligence.

7. Advertising and Sponsorship

Part of the Site may contain advertising and sponsorship. Advertisers and Sponsors are responsible for ensuring that material submitted for inclusion on the Site complies with relevant laws and codes. We will not be responsible for any error or inaccuracy in advertising and sponsorship.

8. Governing Law

These terms and conditions are governed and construed in accordance with the laws of India. You agree that the Indian court shall have exclusive jurisdiction but we may use another court if we choose.

9. Miscellaneous

You may not assign, sub-license or otherwise transfer any of your rights under these Terms and Conditions.

If any provision of these Terms and Conditions is found to be invalid by any court having competent jurisdiction, the invalidity of that provision will not affect the validity of the remaining provisions of these Terms and Conditions, which shall remain in full force and effect.

We shall not be responsible for any breach of these Terms and Conditions caused by circumstances beyond its control.

(Date:8/31/2014)... past several decades, malaria diagnosis has changed very little. After ... the blood across a glass slide, stains it with a ... parasite, which causes the disease. This approach gives an accurate ... an important measure of disease severity but is not ... research team from the Singapore-MIT Alliance for Research and Technology ...
(Date:8/29/2014)... Scientists at the Barshop Institute for Longevity and Aging ... UT Health Science Center at San Antonio, have found ... longest-lived rodent, the naked mole rat. , They ... mole rats protects and alters the activity of the ... , The factor also protects proteasome function in human, ...
(Date:8/29/2014)... climatic shifts over the last 120,000 years may ... team of researchers led by City College of ... new biodiversity metric called "phylogeographic endemism." , It ... within species is restricted in geographical space. , ... 14 other researchers from institutions in Brazil, Australia ...
Breaking Biology News(10 mins):A new way to diagnose malaria 2A new way to diagnose malaria 3Factor in naked mole rat's cells enhances protein integrity 2CCNY team defines new biodiversity metric 2
... , Simultaneous targeting of two different molecules in cancer ... and stop metastasis, scientists at the University of California, ... effectiveness of combination treatments that include drugs like Avastin. ... a type of cancer known as neuroendocrine pancreatic tumors, ...
... German . Hydrofluorocarbons (HFCs), which have been ... CFCs, are also climatically very active and many are also ... international team of researchers recommends that the most potent of ... side effect of the Montreal Protocol for the global climate. ...
... affects the air, it also seeps under the asphalt and ... chemist at the University of the Basque Country (UPV/EHU), has ... impact of the metals emitted by cars. Likewise, he has ... and for this purpose has taken samples from roadsides in ...
Cached Biology News:Cancer therapy more potent when it hits 2 targets 2Cancer therapy more potent when it hits 2 targets 3Protecting the climate by reducing fluorinated greenhouse gas emissions 2Protecting the climate by reducing fluorinated greenhouse gas emissions 3Car tracks beyond the asphalt 2Car tracks beyond the asphalt 3
(Date:9/1/2014)... (PRWEB) September 01, 2014 "Women struggle ... These hormonal daily changes begin as early as 15, ... their lives negotiating the ups and downs of hormone ... thin or even healthy sizes seems to rage against ... As a woman in her 40's begin to face ...
(Date:9/1/2014)... September 01, 2014 As well as ... Derek is currently pursuing counselor certification in Louisiana. ... through the CPI training program as well as the ... have grown both personally and professionally. I am ... am competently able to do so. As a ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 Parties involved ... ahead to the litigation’s status conference in September, where ... be discussed in the Eastern District of Pennsylvania, Bernstein ... of status conferences posted on the Court’s website, the ... 2014 at 10:00 a.m. This is the latest of ...
(Date:9/1/2014)... The Outlier Series announced the next short e-Book ... one of the exceptional women featured in the series’ ... . The title of the upcoming mini e-Book is ... . McClendon is currently a full-time physician’s assistant, and ... WeTV show, Raising Sextuplets. , Jenny was chosen as ...
(Date:9/1/2014)... Psychogenic Non-epileptic Seizures (PNES), also known as ... can have devastating effects on those who develop it. ... they are not produced by electrical anomalies in the ... estimated that the numbers of persons suffering PNES may ... , Dr. Lorna Myers, Director of the Northeast ...
Breaking Medicine News(10 mins):Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 2Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 3Health News:Narconon Louisiana Announces New Certifications For Staff 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 3Health News:The Northeast Regional Epilepsy Group (NEREG) Offers First Conference on Psychogenic Non-epileptic Seizures (PNES) on September 20, 2014 in New Jersey 2
... CINCINNATI, July 28 LCA-Vision Inc. (Nasdaq: LCAV ... Lasik Plus ((R)) brand, today announced financial and operating results for ... , Second Quarter 2009 Operational and Financial Results ... , Revenue was $31.7 million compared with ...
... , , , MINNEAPOLIS, July ... and marketer of state-of-the-art cardiac surgery products, announced today that it ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ) , , ... Focus on Healthcare Conference at the Millennium Broadway Hotel in New ...
... , GLEN ROCK, N.J., July 28 ... of Fingertip Formulary Accounts((R)), a state-of-the art web-based platform ... data and resources at an account level. The ... now provides immediate, real-time integrated provider-level data that includes ...
... , , DENVER, ... caregiver workflow in healthcare environments, today announced that Alegent ... ThinIdentity solution throughout its healthcare system. The first installation ... Iowa. A 278-bed facility, Mercy Hospital has over 1,000 ...
... July 28 According to a new market,research report, ,Drug-Device ... the total drug-device,combination market is expected to be worth US$18.54 ... for nearly 30.9% of the total revenues.,The global market is ... 2014. , Browse 144 market data ...
... ... first analog frame grabber for the National Instruments CompactRIO embedded real-time platform at the ... NIWeek the world,s leading graphical system design conference and exhibition hosted by National Instruments. ... Irvine, CA ...
Cached Medicine News:Health News:LCA-Vision Reports Second Quarter Financial Results 2Health News:LCA-Vision Reports Second Quarter Financial Results 3Health News:LCA-Vision Reports Second Quarter Financial Results 4Health News:LCA-Vision Reports Second Quarter Financial Results 5Health News:LCA-Vision Reports Second Quarter Financial Results 6Health News:LCA-Vision Reports Second Quarter Financial Results 7Health News:LCA-Vision Reports Second Quarter Financial Results 8Health News:LCA-Vision Reports Second Quarter Financial Results 9Health News:LCA-Vision Reports Second Quarter Financial Results 10Health News:LCA-Vision Reports Second Quarter Financial Results 11Health News:LCA-Vision Reports Second Quarter Financial Results 12Health News:LCA-Vision Reports Second Quarter Financial Results 13Health News:LCA-Vision Reports Second Quarter Financial Results 14Health News:ATS Medical to Participate at Upcoming Investor Conferences 2Health News:Fingertip Formulary Accounts(R) Now Offers Access to Comprehensive Real-Time Account Information and Integrated Formulary Data, in a State-of-the Art Web-Based Platform 2Health News:Alegent Health Turns to ThinIdentity(TM) to Improve Caregiver Productivity 2Health News:Alegent Health Turns to ThinIdentity(TM) to Improve Caregiver Productivity 3Health News:Drug-Device Combination Market Worth US$18.54 Billion by 2014 2Health News:Drug-Device Combination Market Worth US$18.54 Billion by 2014 3Health News:MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Advantage 2Health News:MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Advantage 3